Income tax expense · 2015–2025

Lakefront Biotherapeutics income tax expense

−$21.0M−$19.1M · FY2025

Lakefront Biotherapeutics (LKFT) reported −$21.0M in income tax expense for fiscal 2025, −$19.1M from the year before.

−$1.4M2015$260,1222016$223,6772017$970,7452018−$184,7132019$1.4M2020$1.6M2021$602,3442022$10.4M2023−$2.0M2024−$21.0M2025
Lakefront Biotherapeutics — Income tax expense, 2015–2025
Fiscal yearIncome tax expenseChangeFiling
FY20252025-12-31−$21.0M−$19.1MOpen →
FY20242024-12-31−$2.0M−$12.3MOpen →
FY20232023-12-31$10.4M+1,625.6%Open →
FY20222022-12-31$602,344−63.3%Open →
FY20212021-12-31$1.6M+17.3%Open →
FY20202020-12-31$1.4M+$1.6MOpen →
FY20192019-12-31−$184,713−$1.2MOpen →
FY20182018-12-31$970,745+334.0%Open →
FY20172017-12-31$223,677−14.0%Open →
FY20162016-12-31$260,122+$1.6MOpen →
FY20152015-12-31−$1.4M—Open →

Income tax expense — Income tax expense is the tax a company charged against profit in its income statement for the year. It is not the same as the cash it handed to tax authorities: deferred tax, provisions and timing differences separate the two, often by billions. The cash figure is a different line in the cash-flow statement.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026

Figures are reported under IFRS in EUR and converted to US dollars at ECB reference rates — fiscal 2025 average 0.885 EUR/$ for income items, year-end 0.851 EUR/$ for balance-sheet items.

Income tax expense at companies of similar size

Full ranking by income tax expense →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Lakefront Biotherapeutics income tax expense |url=https://companiesranked.com/en/company/lakefront-biotherapeutics/income-tax-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Lakefront Biotherapeutics income tax expense. CompaniesRanked. https://companiesranked.com/en/company/lakefront-biotherapeutics/income-tax-expense

BibTeX

@misc{companiesranked-en-company-lakefront-biotherapeutics-income-tax-expense-2026,
  author       = {{CompaniesRanked}},
  title        = {{Lakefront Biotherapeutics income tax expense}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/lakefront-biotherapeutics/income-tax-expense}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 20-F · 0001104659-26-035163 · March 26, 2026

{{cite web |title=Lakefront Biotherapeutics income tax expense — 20-F (0001104659-26-035163) |url=https://www.sec.gov/Archives/edgar/data/1421876/000110465926035163/glpg-20251231x20f.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-26}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Lakefront Biotherapeutics overview